nodes	percent_of_prediction	percent_of_DWPC	metapath
Leucovorin—ABCC3—Conjugated Estrogens—osteoporosis	0.235	0.352	CbGbCtD
Leucovorin—ABCC4—Conjugated Estrogens—osteoporosis	0.179	0.269	CbGbCtD
Leucovorin—ABCC2—Ethinyl Estradiol—osteoporosis	0.145	0.218	CbGbCtD
Leucovorin—ABCC2—Conjugated Estrogens—osteoporosis	0.107	0.16	CbGbCtD
Leucovorin—ABCC3—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.0109	0.112	CbGpPWpGaD
Leucovorin—ABCC4—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.0103	0.106	CbGpPWpGaD
Leucovorin—ABCC2—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.00865	0.089	CbGpPWpGaD
Leucovorin—TYMS—One Carbon Metabolism—ATIC—osteoporosis	0.00464	0.0478	CbGpPWpGaD
Leucovorin—Pemetrexed—ATIC—osteoporosis	0.00408	0.35	CrCbGaD
Leucovorin—Tetrahydrofolic acid—ATIC—osteoporosis	0.00329	0.282	CrCbGaD
Leucovorin—Methotrexate—ATIC—osteoporosis	0.00225	0.193	CrCbGaD
Leucovorin—ABCC3—Bile acid and bile salt metabolism—CYP27A1—osteoporosis	0.00208	0.0214	CbGpPWpGaD
Leucovorin—ABCC4—Platelet degranulation—WDR1—osteoporosis	0.00206	0.0212	CbGpPWpGaD
Leucovorin—TYMS—Nucleotide metabolism—ATIC—osteoporosis	0.00205	0.0211	CbGpPWpGaD
Leucovorin—TYMS—Nucleotide metabolism—PNP—osteoporosis	0.00205	0.0211	CbGpPWpGaD
Leucovorin—ABCC4—Response to elevated platelet cytosolic Ca2+—WDR1—osteoporosis	0.00196	0.0202	CbGpPWpGaD
Leucovorin—TYMS—Circadian rythm related genes—ID4—osteoporosis	0.00183	0.0188	CbGpPWpGaD
Leucovorin—ABCC3—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.00174	0.0179	CbGpPWpGaD
Leucovorin—ABCC4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.00164	0.0169	CbGpPWpGaD
Leucovorin—ABCC4—Platelet degranulation—CAP1—osteoporosis	0.00163	0.0168	CbGpPWpGaD
Leucovorin—TYMS—Levorphanol—Estradiol—osteoporosis	0.00161	0.469	CbGdCrCtD
Leucovorin—ABCC4—Response to elevated platelet cytosolic Ca2+—CAP1—osteoporosis	0.00155	0.016	CbGpPWpGaD
Leucovorin—ABCC2—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.00138	0.0142	CbGpPWpGaD
Leucovorin—TYMS—One Carbon Metabolism—MTHFR—osteoporosis	0.00121	0.0125	CbGpPWpGaD
Leucovorin—ABCC4—Platelet degranulation—PLEK—osteoporosis	0.00118	0.0122	CbGpPWpGaD
Leucovorin—ABCC4—Response to elevated platelet cytosolic Ca2+—PLEK—osteoporosis	0.00113	0.0116	CbGpPWpGaD
Leucovorin—TYMS—Trans-sulfuration and one carbon metabolism—MTHFR—osteoporosis	0.00109	0.0112	CbGpPWpGaD
Leucovorin—TYMS—Fluoropyrimidine Activity—MTHFR—osteoporosis	0.00106	0.011	CbGpPWpGaD
Leucovorin—TYMS—Danazol—Ethinyl Estradiol—osteoporosis	0.00106	0.309	CbGdCrCtD
Leucovorin—ABCC4—Platelet degranulation—TLN1—osteoporosis	0.00102	0.0105	CbGpPWpGaD
Leucovorin—ABCC4—Platelet degranulation—VCL—osteoporosis	0.00101	0.0104	CbGpPWpGaD
Leucovorin—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.001	0.0103	CbGpPWpGaD
Leucovorin—ABCC4—Response to elevated platelet cytosolic Ca2+—TLN1—osteoporosis	0.000971	0.01	CbGpPWpGaD
Leucovorin—ABCC4—Response to elevated platelet cytosolic Ca2+—VCL—osteoporosis	0.000958	0.00986	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—WDR1—osteoporosis	0.000913	0.0094	CbGpPWpGaD
Leucovorin—ABCC3—Fluoropyrimidine Activity—MTHFR—osteoporosis	0.000881	0.00907	CbGpPWpGaD
Leucovorin—ABCC4—Fluoropyrimidine Activity—MTHFR—osteoporosis	0.000829	0.00853	CbGpPWpGaD
Leucovorin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000794	0.00817	CbGpPWpGaD
Leucovorin—ABCC4—Platelet degranulation—FGA—osteoporosis	0.000762	0.00785	CbGpPWpGaD
Leucovorin—TYMS—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.000761	0.222	CbGdCrCtD
Leucovorin—Tetrahydrofolic acid—MTHFR—osteoporosis	0.000759	0.0652	CrCbGaD
Leucovorin—Folic Acid—MTHFR—osteoporosis	0.000759	0.0652	CrCbGaD
Leucovorin—ABCC4—Response to elevated platelet cytosolic Ca2+—FGA—osteoporosis	0.000726	0.00748	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—CAP1—osteoporosis	0.000722	0.00743	CbGpPWpGaD
Leucovorin—ABCC4—Platelet degranulation—FGB—osteoporosis	0.000693	0.00714	CbGpPWpGaD
Leucovorin—TYMS—G1/S Transition—PSMA5—osteoporosis	0.000671	0.00691	CbGpPWpGaD
Leucovorin—TYMS—G1/S Transition—PSMA2—osteoporosis	0.000671	0.00691	CbGpPWpGaD
Leucovorin—ABCC4—Response to elevated platelet cytosolic Ca2+—FGB—osteoporosis	0.00066	0.0068	CbGpPWpGaD
Leucovorin—TYMS—Nucleotide metabolism—GPX1—osteoporosis	0.00058	0.00597	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—MGLL—osteoporosis	0.000573	0.00591	CbGpPWpGaD
Leucovorin—TYMS—Mitotic G1-G1/S phases—PSMA2—osteoporosis	0.000566	0.00583	CbGpPWpGaD
Leucovorin—TYMS—Mitotic G1-G1/S phases—PSMA5—osteoporosis	0.000566	0.00583	CbGpPWpGaD
Leucovorin—Dyspepsia—Ibandronate—osteoporosis	0.000551	0.00248	CcSEcCtD
Leucovorin—Constipation—Alendronate—osteoporosis	0.000549	0.00248	CcSEcCtD
Leucovorin—Erythema—Zoledronate—osteoporosis	0.000549	0.00247	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000546	0.00246	CcSEcCtD
Leucovorin—Discomfort—Ethinyl Estradiol—osteoporosis	0.000545	0.00246	CcSEcCtD
Leucovorin—Decreased appetite—Ibandronate—osteoporosis	0.000544	0.00245	CcSEcCtD
Leucovorin—Malaise—Pamidronate—osteoporosis	0.000542	0.00244	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Ibandronate—osteoporosis	0.00054	0.00243	CcSEcCtD
Leucovorin—Fatigue—Ibandronate—osteoporosis	0.000539	0.00243	CcSEcCtD
Leucovorin—ABCC4—Ectoderm Differentiation—TNFRSF11B—osteoporosis	0.000539	0.00555	CbGpPWpGaD
Leucovorin—Syncope—Pamidronate—osteoporosis	0.000539	0.00243	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	0.000538	0.00554	CbGpPWpGaD
Leucovorin—Leukopenia—Pamidronate—osteoporosis	0.000538	0.00242	CcSEcCtD
Leucovorin—Dysgeusia—Zoledronate—osteoporosis	0.000537	0.00242	CcSEcCtD
Leucovorin—Alopecia—Conjugated Estrogens—osteoporosis	0.000536	0.00242	CcSEcCtD
Leucovorin—Constipation—Ibandronate—osteoporosis	0.000535	0.00241	CcSEcCtD
Leucovorin—Pruritus—Etidronic acid—osteoporosis	0.000534	0.0024	CcSEcCtD
Leucovorin—Gastrointestinal pain—Estropipate—osteoporosis	0.000533	0.0024	CcSEcCtD
Leucovorin—Decreased appetite—Calcitriol—osteoporosis	0.000532	0.0024	CcSEcCtD
Leucovorin—Neuropathy peripheral—Estradiol—osteoporosis	0.00053	0.00239	CcSEcCtD
Leucovorin—ABCC4—Ectoderm Differentiation—NFATC1—osteoporosis	0.00053	0.00546	CbGpPWpGaD
Leucovorin—Feeling abnormal—Alendronate—osteoporosis	0.00053	0.00239	CcSEcCtD
Leucovorin—Erythema—Conjugated Estrogens—osteoporosis	0.000528	0.00238	CcSEcCtD
Leucovorin—Loss of consciousness—Pamidronate—osteoporosis	0.000528	0.00238	CcSEcCtD
Leucovorin—Gastrointestinal pain—Alendronate—osteoporosis	0.000525	0.00237	CcSEcCtD
Leucovorin—Infection—Ethinyl Estradiol—osteoporosis	0.000525	0.00237	CcSEcCtD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—PLEK—osteoporosis	0.000525	0.0054	CbGpPWpGaD
Leucovorin—Constipation—Calcitriol—osteoporosis	0.000524	0.00236	CcSEcCtD
Leucovorin—Convulsion—Pamidronate—osteoporosis	0.00052	0.00235	CcSEcCtD
Leucovorin—Methotrexate—MTHFR—osteoporosis	0.000519	0.0446	CrCbGaD
Leucovorin—Urticaria—Estropipate—osteoporosis	0.000518	0.00234	CcSEcCtD
Leucovorin—Dysgeusia—Conjugated Estrogens—osteoporosis	0.000517	0.00233	CcSEcCtD
Leucovorin—Gastrointestinal pain—Raloxifene—osteoporosis	0.000517	0.00233	CcSEcCtD
Leucovorin—Diarrhoea—Etidronic acid—osteoporosis	0.000516	0.00233	CcSEcCtD
Leucovorin—Abdominal pain—Estropipate—osteoporosis	0.000516	0.00232	CcSEcCtD
Leucovorin—Body temperature increased—Estropipate—osteoporosis	0.000516	0.00232	CcSEcCtD
Leucovorin—Feeling abnormal—Ibandronate—osteoporosis	0.000516	0.00232	CcSEcCtD
Leucovorin—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000514	0.00232	CcSEcCtD
Leucovorin—Infection—Risedronate—osteoporosis	0.000512	0.00231	CcSEcCtD
Leucovorin—Gastrointestinal pain—Ibandronate—osteoporosis	0.000512	0.00231	CcSEcCtD
Leucovorin—Urticaria—Alendronate—osteoporosis	0.00051	0.0023	CcSEcCtD
Leucovorin—Ill-defined disorder—Zoledronate—osteoporosis	0.000509	0.00229	CcSEcCtD
Leucovorin—Body temperature increased—Alendronate—osteoporosis	0.000508	0.00229	CcSEcCtD
Leucovorin—Abdominal pain—Alendronate—osteoporosis	0.000508	0.00229	CcSEcCtD
Leucovorin—Shock—Risedronate—osteoporosis	0.000507	0.00229	CcSEcCtD
Leucovorin—ABCC4—Ectoderm Differentiation—WNT1—osteoporosis	0.000506	0.00521	CbGpPWpGaD
Leucovorin—Discomfort—Pamidronate—osteoporosis	0.000505	0.00228	CcSEcCtD
Leucovorin—Skin disorder—Risedronate—osteoporosis	0.000501	0.00226	CcSEcCtD
Leucovorin—Gastrointestinal pain—Calcitriol—osteoporosis	0.000501	0.00226	CcSEcCtD
Leucovorin—Body temperature increased—Raloxifene—osteoporosis	0.0005	0.00225	CcSEcCtD
Leucovorin—Abdominal pain—Raloxifene—osteoporosis	0.0005	0.00225	CcSEcCtD
Leucovorin—Urticaria—Ibandronate—osteoporosis	0.000497	0.00224	CcSEcCtD
Leucovorin—Malaise—Zoledronate—osteoporosis	0.000495	0.00223	CcSEcCtD
Leucovorin—Abdominal pain—Ibandronate—osteoporosis	0.000495	0.00223	CcSEcCtD
Leucovorin—Body temperature increased—Ibandronate—osteoporosis	0.000495	0.00223	CcSEcCtD
Leucovorin—Confusional state—Pamidronate—osteoporosis	0.000494	0.00223	CcSEcCtD
Leucovorin—Syncope—Zoledronate—osteoporosis	0.000492	0.00222	CcSEcCtD
Leucovorin—Leukopenia—Zoledronate—osteoporosis	0.000491	0.00221	CcSEcCtD
Leucovorin—Anaphylactic shock—Pamidronate—osteoporosis	0.00049	0.00221	CcSEcCtD
Leucovorin—Infection—Pamidronate—osteoporosis	0.000487	0.00219	CcSEcCtD
Leucovorin—Urticaria—Calcitriol—osteoporosis	0.000487	0.00219	CcSEcCtD
Leucovorin—Abdominal pain—Calcitriol—osteoporosis	0.000484	0.00218	CcSEcCtD
Leucovorin—Body temperature increased—Calcitriol—osteoporosis	0.000484	0.00218	CcSEcCtD
Leucovorin—Shock—Pamidronate—osteoporosis	0.000482	0.00217	CcSEcCtD
Leucovorin—Loss of consciousness—Zoledronate—osteoporosis	0.000482	0.00217	CcSEcCtD
Leucovorin—Hypersensitivity—Estropipate—osteoporosis	0.000481	0.00217	CcSEcCtD
Leucovorin—Thrombocytopenia—Pamidronate—osteoporosis	0.00048	0.00216	CcSEcCtD
Leucovorin—Vomiting—Etidronic acid—osteoporosis	0.000479	0.00216	CcSEcCtD
Leucovorin—Rash—Etidronic acid—osteoporosis	0.000475	0.00214	CcSEcCtD
Leucovorin—Convulsion—Zoledronate—osteoporosis	0.000475	0.00214	CcSEcCtD
Leucovorin—Dermatitis—Etidronic acid—osteoporosis	0.000475	0.00214	CcSEcCtD
Leucovorin—Syncope—Conjugated Estrogens—osteoporosis	0.000474	0.00214	CcSEcCtD
Leucovorin—Hypersensitivity—Alendronate—osteoporosis	0.000473	0.00213	CcSEcCtD
Leucovorin—ABCC4—Hemostasis—WDR1—osteoporosis	0.000471	0.00485	CbGpPWpGaD
Leucovorin—Asthenia—Estropipate—osteoporosis	0.000468	0.00211	CcSEcCtD
Leucovorin—Anorexia—Pamidronate—osteoporosis	0.000467	0.00211	CcSEcCtD
Leucovorin—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000464	0.00209	CcSEcCtD
Leucovorin—Pruritus—Estropipate—osteoporosis	0.000462	0.00208	CcSEcCtD
Leucovorin—Discomfort—Zoledronate—osteoporosis	0.000461	0.00208	CcSEcCtD
Leucovorin—Asthenia—Alendronate—osteoporosis	0.000461	0.00208	CcSEcCtD
Leucovorin—Hypersensitivity—Ibandronate—osteoporosis	0.000461	0.00208	CcSEcCtD
Leucovorin—Dyspnoea—Risedronate—osteoporosis	0.00046	0.00207	CcSEcCtD
Leucovorin—Convulsion—Conjugated Estrogens—osteoporosis	0.000458	0.00206	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000457	0.00206	CcSEcCtD
Leucovorin—Fatigue—Ethinyl Estradiol—osteoporosis	0.000456	0.00206	CcSEcCtD
Leucovorin—Pruritus—Alendronate—osteoporosis	0.000455	0.00205	CcSEcCtD
Leucovorin—Dyspepsia—Risedronate—osteoporosis	0.000454	0.00205	CcSEcCtD
Leucovorin—Constipation—Ethinyl Estradiol—osteoporosis	0.000452	0.00204	CcSEcCtD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—TLN1—osteoporosis	0.000452	0.00466	CbGpPWpGaD
Leucovorin—Confusional state—Zoledronate—osteoporosis	0.000451	0.00203	CcSEcCtD
Leucovorin—Hypersensitivity—Calcitriol—osteoporosis	0.000451	0.00203	CcSEcCtD
Leucovorin—Asthenia—Ibandronate—osteoporosis	0.000449	0.00202	CcSEcCtD
Leucovorin—Nausea—Etidronic acid—osteoporosis	0.000448	0.00202	CcSEcCtD
Leucovorin—Anaphylactic shock—Zoledronate—osteoporosis	0.000448	0.00202	CcSEcCtD
Leucovorin—Diarrhoea—Estropipate—osteoporosis	0.000446	0.00201	CcSEcCtD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—VCL—osteoporosis	0.000446	0.00459	CbGpPWpGaD
Leucovorin—Gastrointestinal disorder—Risedronate—osteoporosis	0.000445	0.00201	CcSEcCtD
Leucovorin—Infection—Zoledronate—osteoporosis	0.000445	0.002	CcSEcCtD
Leucovorin—Fatigue—Risedronate—osteoporosis	0.000445	0.002	CcSEcCtD
Leucovorin—Pruritus—Ibandronate—osteoporosis	0.000443	0.002	CcSEcCtD
Leucovorin—Constipation—Risedronate—osteoporosis	0.000441	0.00199	CcSEcCtD
Leucovorin—Shock—Zoledronate—osteoporosis	0.00044	0.00199	CcSEcCtD
Leucovorin—Diarrhoea—Alendronate—osteoporosis	0.00044	0.00198	CcSEcCtD
Leucovorin—Asthenia—Calcitriol—osteoporosis	0.000439	0.00198	CcSEcCtD
Leucovorin—Thrombocytopenia—Zoledronate—osteoporosis	0.000438	0.00198	CcSEcCtD
Leucovorin—Dyspnoea—Pamidronate—osteoporosis	0.000437	0.00197	CcSEcCtD
Leucovorin—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000436	0.00196	CcSEcCtD
Leucovorin—Chills—Estradiol—osteoporosis	0.000436	0.00196	CcSEcCtD
Leucovorin—Skin disorder—Zoledronate—osteoporosis	0.000435	0.00196	CcSEcCtD
Leucovorin—Pruritus—Calcitriol—osteoporosis	0.000433	0.00195	CcSEcCtD
Leucovorin—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000432	0.00195	CcSEcCtD
Leucovorin—Diarrhoea—Raloxifene—osteoporosis	0.000432	0.00195	CcSEcCtD
Leucovorin—Dyspepsia—Pamidronate—osteoporosis	0.000431	0.00194	CcSEcCtD
Leucovorin—Dizziness—Estropipate—osteoporosis	0.000431	0.00194	CcSEcCtD
Leucovorin—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000431	0.00194	CcSEcCtD
Leucovorin—Alopecia—Estradiol—osteoporosis	0.000429	0.00193	CcSEcCtD
Leucovorin—Infection—Conjugated Estrogens—osteoporosis	0.000428	0.00193	CcSEcCtD
Leucovorin—Diarrhoea—Ibandronate—osteoporosis	0.000428	0.00193	CcSEcCtD
Leucovorin—Anorexia—Zoledronate—osteoporosis	0.000427	0.00192	CcSEcCtD
Leucovorin—Decreased appetite—Pamidronate—osteoporosis	0.000426	0.00192	CcSEcCtD
Leucovorin—Dizziness—Alendronate—osteoporosis	0.000425	0.00192	CcSEcCtD
Leucovorin—Shock—Conjugated Estrogens—osteoporosis	0.000424	0.00191	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000423	0.00191	CcSEcCtD
Leucovorin—Erythema—Estradiol—osteoporosis	0.000423	0.00191	CcSEcCtD
Leucovorin—Fatigue—Pamidronate—osteoporosis	0.000423	0.0019	CcSEcCtD
Leucovorin—Gastrointestinal pain—Risedronate—osteoporosis	0.000422	0.0019	CcSEcCtD
Leucovorin—Urticaria—Ethinyl Estradiol—osteoporosis	0.00042	0.00189	CcSEcCtD
Leucovorin—Constipation—Pamidronate—osteoporosis	0.000419	0.00189	CcSEcCtD
Leucovorin—Diarrhoea—Calcitriol—osteoporosis	0.000419	0.00189	CcSEcCtD
Leucovorin—Skin disorder—Conjugated Estrogens—osteoporosis	0.000419	0.00189	CcSEcCtD
Leucovorin—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000418	0.00188	CcSEcCtD
Leucovorin—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000418	0.00188	CcSEcCtD
Leucovorin—Dizziness—Raloxifene—osteoporosis	0.000418	0.00188	CcSEcCtD
Leucovorin—Vomiting—Estropipate—osteoporosis	0.000415	0.00187	CcSEcCtD
Leucovorin—Dysgeusia—Estradiol—osteoporosis	0.000414	0.00187	CcSEcCtD
Leucovorin—Dizziness—Ibandronate—osteoporosis	0.000414	0.00186	CcSEcCtD
Leucovorin—Rash—Estropipate—osteoporosis	0.000411	0.00185	CcSEcCtD
Leucovorin—Dermatitis—Estropipate—osteoporosis	0.000411	0.00185	CcSEcCtD
Leucovorin—Anorexia—Conjugated Estrogens—osteoporosis	0.000411	0.00185	CcSEcCtD
Leucovorin—Urticaria—Risedronate—osteoporosis	0.00041	0.00185	CcSEcCtD
Leucovorin—Vomiting—Alendronate—osteoporosis	0.000409	0.00184	CcSEcCtD
Leucovorin—Abdominal pain—Risedronate—osteoporosis	0.000408	0.00184	CcSEcCtD
Leucovorin—Body temperature increased—Risedronate—osteoporosis	0.000408	0.00184	CcSEcCtD
Leucovorin—Rash—Alendronate—osteoporosis	0.000405	0.00183	CcSEcCtD
Leucovorin—Dermatitis—Alendronate—osteoporosis	0.000405	0.00182	CcSEcCtD
Leucovorin—Feeling abnormal—Pamidronate—osteoporosis	0.000404	0.00182	CcSEcCtD
Leucovorin—Vomiting—Raloxifene—osteoporosis	0.000402	0.00181	CcSEcCtD
Leucovorin—Gastrointestinal pain—Pamidronate—osteoporosis	0.000401	0.00181	CcSEcCtD
Leucovorin—Dyspnoea—Zoledronate—osteoporosis	0.000399	0.0018	CcSEcCtD
Leucovorin—Rash—Raloxifene—osteoporosis	0.000398	0.0018	CcSEcCtD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000398	0.0041	CbGpPWpGaD
Leucovorin—Dermatitis—Raloxifene—osteoporosis	0.000398	0.00179	CcSEcCtD
Leucovorin—Vomiting—Ibandronate—osteoporosis	0.000398	0.00179	CcSEcCtD
Leucovorin—Rash—Ibandronate—osteoporosis	0.000394	0.00178	CcSEcCtD
Leucovorin—Dermatitis—Ibandronate—osteoporosis	0.000394	0.00178	CcSEcCtD
Leucovorin—Dyspepsia—Zoledronate—osteoporosis	0.000394	0.00178	CcSEcCtD
Leucovorin—Ill-defined disorder—Estradiol—osteoporosis	0.000392	0.00177	CcSEcCtD
Leucovorin—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00039	0.00176	CcSEcCtD
Leucovorin—Vomiting—Calcitriol—osteoporosis	0.000389	0.00176	CcSEcCtD
Leucovorin—Decreased appetite—Zoledronate—osteoporosis	0.000389	0.00175	CcSEcCtD
Leucovorin—Nausea—Estropipate—osteoporosis	0.000388	0.00175	CcSEcCtD
Leucovorin—Abdominal pain—Pamidronate—osteoporosis	0.000387	0.00175	CcSEcCtD
Leucovorin—Body temperature increased—Pamidronate—osteoporosis	0.000387	0.00175	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000386	0.00174	CcSEcCtD
Leucovorin—Rash—Calcitriol—osteoporosis	0.000386	0.00174	CcSEcCtD
Leucovorin—Fatigue—Zoledronate—osteoporosis	0.000386	0.00174	CcSEcCtD
Leucovorin—Dermatitis—Calcitriol—osteoporosis	0.000386	0.00174	CcSEcCtD
Leucovorin—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000384	0.00173	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	0.000383	0.00394	CbGpPWpGaD
Leucovorin—Constipation—Zoledronate—osteoporosis	0.000383	0.00173	CcSEcCtD
Leucovorin—Nausea—Alendronate—osteoporosis	0.000382	0.00172	CcSEcCtD
Leucovorin—Malaise—Estradiol—osteoporosis	0.000381	0.00172	CcSEcCtD
Leucovorin—Hypersensitivity—Risedronate—osteoporosis	0.00038	0.00171	CcSEcCtD
Leucovorin—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000379	0.00171	CcSEcCtD
Leucovorin—Asthenia—Ethinyl Estradiol—osteoporosis	0.000379	0.00171	CcSEcCtD
Leucovorin—Syncope—Estradiol—osteoporosis	0.000379	0.00171	CcSEcCtD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000378	0.00389	CbGpPWpGaD
Leucovorin—Nausea—Raloxifene—osteoporosis	0.000375	0.00169	CcSEcCtD
Leucovorin—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000375	0.00169	CcSEcCtD
Leucovorin—Pruritus—Ethinyl Estradiol—osteoporosis	0.000374	0.00169	CcSEcCtD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—RAP1A—osteoporosis	0.000373	0.00384	CbGpPWpGaD
Leucovorin—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000372	0.00168	CcSEcCtD
Leucovorin—ABCC4—Hemostasis—CAP1—osteoporosis	0.000372	0.00383	CbGpPWpGaD
Leucovorin—Fatigue—Conjugated Estrogens—osteoporosis	0.000372	0.00168	CcSEcCtD
Leucovorin—Nausea—Ibandronate—osteoporosis	0.000372	0.00168	CcSEcCtD
Leucovorin—Loss of consciousness—Estradiol—osteoporosis	0.000372	0.00167	CcSEcCtD
Leucovorin—Asthenia—Risedronate—osteoporosis	0.00037	0.00167	CcSEcCtD
Leucovorin—Feeling abnormal—Zoledronate—osteoporosis	0.000369	0.00166	CcSEcCtD
Leucovorin—Constipation—Conjugated Estrogens—osteoporosis	0.000369	0.00166	CcSEcCtD
Leucovorin—Gastrointestinal pain—Zoledronate—osteoporosis	0.000366	0.00165	CcSEcCtD
Leucovorin—Pruritus—Risedronate—osteoporosis	0.000365	0.00164	CcSEcCtD
Leucovorin—Nausea—Calcitriol—osteoporosis	0.000364	0.00164	CcSEcCtD
Leucovorin—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000362	0.00163	CcSEcCtD
Leucovorin—Hypersensitivity—Pamidronate—osteoporosis	0.000361	0.00163	CcSEcCtD
Leucovorin—Urticaria—Zoledronate—osteoporosis	0.000356	0.0016	CcSEcCtD
Leucovorin—Discomfort—Estradiol—osteoporosis	0.000356	0.0016	CcSEcCtD
Leucovorin—Abdominal pain—Zoledronate—osteoporosis	0.000354	0.0016	CcSEcCtD
Leucovorin—Body temperature increased—Zoledronate—osteoporosis	0.000354	0.0016	CcSEcCtD
Leucovorin—Diarrhoea—Risedronate—osteoporosis	0.000353	0.00159	CcSEcCtD
Leucovorin—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000352	0.00159	CcSEcCtD
Leucovorin—Asthenia—Pamidronate—osteoporosis	0.000352	0.00159	CcSEcCtD
Leucovorin—Dizziness—Ethinyl Estradiol—osteoporosis	0.00035	0.00158	CcSEcCtD
Leucovorin—Confusional state—Estradiol—osteoporosis	0.000348	0.00157	CcSEcCtD
Leucovorin—Pruritus—Pamidronate—osteoporosis	0.000347	0.00156	CcSEcCtD
Leucovorin—Anaphylactic shock—Estradiol—osteoporosis	0.000345	0.00156	CcSEcCtD
Leucovorin—Infection—Estradiol—osteoporosis	0.000343	0.00155	CcSEcCtD
Leucovorin—Urticaria—Conjugated Estrogens—osteoporosis	0.000342	0.00154	CcSEcCtD
Leucovorin—Dizziness—Risedronate—osteoporosis	0.000341	0.00154	CcSEcCtD
Leucovorin—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000341	0.00154	CcSEcCtD
Leucovorin—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000341	0.00154	CcSEcCtD
Leucovorin—Shock—Estradiol—osteoporosis	0.000339	0.00153	CcSEcCtD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—FGA—osteoporosis	0.000338	0.00348	CbGpPWpGaD
Leucovorin—Vomiting—Ethinyl Estradiol—osteoporosis	0.000336	0.00152	CcSEcCtD
Leucovorin—Diarrhoea—Pamidronate—osteoporosis	0.000335	0.00151	CcSEcCtD
Leucovorin—Skin disorder—Estradiol—osteoporosis	0.000335	0.00151	CcSEcCtD
Leucovorin—Rash—Ethinyl Estradiol—osteoporosis	0.000333	0.0015	CcSEcCtD
Leucovorin—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000333	0.0015	CcSEcCtD
Leucovorin—Hypersensitivity—Zoledronate—osteoporosis	0.00033	0.00149	CcSEcCtD
Leucovorin—Vomiting—Risedronate—osteoporosis	0.000328	0.00148	CcSEcCtD
Leucovorin—Rash—Risedronate—osteoporosis	0.000325	0.00147	CcSEcCtD
Leucovorin—Dermatitis—Risedronate—osteoporosis	0.000325	0.00146	CcSEcCtD
Leucovorin—Dizziness—Pamidronate—osteoporosis	0.000324	0.00146	CcSEcCtD
Leucovorin—Asthenia—Zoledronate—osteoporosis	0.000321	0.00145	CcSEcCtD
Leucovorin—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000318	0.00143	CcSEcCtD
Leucovorin—Pruritus—Zoledronate—osteoporosis	0.000317	0.00143	CcSEcCtD
Leucovorin—Nausea—Ethinyl Estradiol—osteoporosis	0.000314	0.00142	CcSEcCtD
Leucovorin—ABCC4—Platelet degranulation—IGF1—osteoporosis	0.000314	0.00323	CbGpPWpGaD
Leucovorin—Vomiting—Pamidronate—osteoporosis	0.000312	0.0014	CcSEcCtD
Leucovorin—Asthenia—Conjugated Estrogens—osteoporosis	0.000309	0.00139	CcSEcCtD
Leucovorin—Rash—Pamidronate—osteoporosis	0.000309	0.00139	CcSEcCtD
Leucovorin—Dermatitis—Pamidronate—osteoporosis	0.000309	0.00139	CcSEcCtD
Leucovorin—Dyspnoea—Estradiol—osteoporosis	0.000308	0.00139	CcSEcCtD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—FGB—osteoporosis	0.000308	0.00317	CbGpPWpGaD
Leucovorin—Diarrhoea—Zoledronate—osteoporosis	0.000306	0.00138	CcSEcCtD
Leucovorin—Nausea—Risedronate—osteoporosis	0.000306	0.00138	CcSEcCtD
Leucovorin—Pruritus—Conjugated Estrogens—osteoporosis	0.000305	0.00137	CcSEcCtD
Leucovorin—Dyspepsia—Estradiol—osteoporosis	0.000304	0.00137	CcSEcCtD
Leucovorin—Decreased appetite—Estradiol—osteoporosis	0.0003	0.00135	CcSEcCtD
Leucovorin—ABCC4—Response to elevated platelet cytosolic Ca2+—IGF1—osteoporosis	0.000299	0.00308	CbGpPWpGaD
Leucovorin—Gastrointestinal disorder—Estradiol—osteoporosis	0.000298	0.00134	CcSEcCtD
Leucovorin—Fatigue—Estradiol—osteoporosis	0.000297	0.00134	CcSEcCtD
Leucovorin—Dizziness—Zoledronate—osteoporosis	0.000296	0.00133	CcSEcCtD
Leucovorin—ABCC4—Hemostasis—MGLL—osteoporosis	0.000296	0.00304	CbGpPWpGaD
Leucovorin—Constipation—Estradiol—osteoporosis	0.000295	0.00133	CcSEcCtD
Leucovorin—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000295	0.00133	CcSEcCtD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000294	0.00302	CbGpPWpGaD
Leucovorin—ABCC3—NRF2 pathway—AGER—osteoporosis	0.000293	0.00301	CbGpPWpGaD
Leucovorin—Nausea—Pamidronate—osteoporosis	0.000291	0.00131	CcSEcCtD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000286	0.00295	CbGpPWpGaD
Leucovorin—Dizziness—Conjugated Estrogens—osteoporosis	0.000285	0.00128	CcSEcCtD
Leucovorin—Vomiting—Zoledronate—osteoporosis	0.000285	0.00128	CcSEcCtD
Leucovorin—Feeling abnormal—Estradiol—osteoporosis	0.000284	0.00128	CcSEcCtD
Leucovorin—Rash—Zoledronate—osteoporosis	0.000282	0.00127	CcSEcCtD
Leucovorin—Gastrointestinal pain—Estradiol—osteoporosis	0.000282	0.00127	CcSEcCtD
Leucovorin—Dermatitis—Zoledronate—osteoporosis	0.000282	0.00127	CcSEcCtD
Leucovorin—ABCC4—NRF2 pathway—AGER—osteoporosis	0.000275	0.00283	CbGpPWpGaD
Leucovorin—Vomiting—Conjugated Estrogens—osteoporosis	0.000274	0.00124	CcSEcCtD
Leucovorin—Urticaria—Estradiol—osteoporosis	0.000274	0.00124	CcSEcCtD
Leucovorin—Abdominal pain—Estradiol—osteoporosis	0.000273	0.00123	CcSEcCtD
Leucovorin—Body temperature increased—Estradiol—osteoporosis	0.000273	0.00123	CcSEcCtD
Leucovorin—Rash—Conjugated Estrogens—osteoporosis	0.000272	0.00123	CcSEcCtD
Leucovorin—Dermatitis—Conjugated Estrogens—osteoporosis	0.000272	0.00122	CcSEcCtD
Leucovorin—ABCC4—Hemostasis—ANXA2—osteoporosis	0.00027	0.00278	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—PLEK—osteoporosis	0.00027	0.00278	CbGpPWpGaD
Leucovorin—Nausea—Zoledronate—osteoporosis	0.000266	0.0012	CcSEcCtD
Leucovorin—TYMS—E2F transcription factor network—MYC—osteoporosis	0.000261	0.00269	CbGpPWpGaD
Leucovorin—Nausea—Conjugated Estrogens—osteoporosis	0.000256	0.00115	CcSEcCtD
Leucovorin—Hypersensitivity—Estradiol—osteoporosis	0.000254	0.00115	CcSEcCtD
Leucovorin—ABCC3—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000249	0.00256	CbGpPWpGaD
Leucovorin—Asthenia—Estradiol—osteoporosis	0.000248	0.00112	CcSEcCtD
Leucovorin—Pruritus—Estradiol—osteoporosis	0.000244	0.0011	CcSEcCtD
Leucovorin—Diarrhoea—Estradiol—osteoporosis	0.000236	0.00106	CcSEcCtD
Leucovorin—ABCC4—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000234	0.00241	CbGpPWpGaD
Leucovorin—TYMS—Circadian rythm related genes—LEP—osteoporosis	0.000234	0.00241	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—TLN1—osteoporosis	0.000233	0.0024	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	0.000232	0.00239	CbGpPWpGaD
Leucovorin—ABCC2—NRF2 pathway—AGER—osteoporosis	0.000232	0.00239	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—VCL—osteoporosis	0.00023	0.00237	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000229	0.00236	CbGpPWpGaD
Leucovorin—Dizziness—Estradiol—osteoporosis	0.000228	0.00103	CcSEcCtD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—MYC—osteoporosis	0.000227	0.00233	CbGpPWpGaD
Leucovorin—Vomiting—Estradiol—osteoporosis	0.000219	0.000989	CcSEcCtD
Leucovorin—Rash—Estradiol—osteoporosis	0.000218	0.000981	CcSEcCtD
Leucovorin—Dermatitis—Estradiol—osteoporosis	0.000217	0.00098	CcSEcCtD
Leucovorin—TYMS—Metabolism—FDPS—osteoporosis	0.000214	0.00221	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PKM—osteoporosis	0.000214	0.00221	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—PSMA2—osteoporosis	0.000208	0.00214	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—PSMA5—osteoporosis	0.000208	0.00214	CbGpPWpGaD
Leucovorin—Nausea—Estradiol—osteoporosis	0.000205	0.000924	CcSEcCtD
Leucovorin—TYMS—Metabolism—GPD2—osteoporosis	0.000203	0.00209	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PGLS—osteoporosis	0.000203	0.00209	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	0.000201	0.00207	CbGpPWpGaD
Leucovorin—ABCC2—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000197	0.00203	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000195	0.002	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—RAP1A—osteoporosis	0.000192	0.00198	CbGpPWpGaD
Leucovorin—TYMS—G1/S Transition—MYC—osteoporosis	0.000189	0.00195	CbGpPWpGaD
Leucovorin—ABCC4—Platelet degranulation—TGFB1—osteoporosis	0.000188	0.00194	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—ATIC—osteoporosis	0.000186	0.00191	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PNP—osteoporosis	0.000186	0.00191	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—PSMA5—osteoporosis	0.000186	0.00191	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—PSMA2—osteoporosis	0.000186	0.00191	CbGpPWpGaD
Leucovorin—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	0.000179	0.00185	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PKM—osteoporosis	0.000177	0.00183	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—FDPS—osteoporosis	0.000177	0.00183	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—FGA—osteoporosis	0.000174	0.00179	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PGLS—osteoporosis	0.000168	0.00173	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—GPD2—osteoporosis	0.000168	0.00173	CbGpPWpGaD
Leucovorin—TYMS—Mitotic G1-G1/S phases—MYC—osteoporosis	0.000159	0.00164	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—FGB—osteoporosis	0.000159	0.00163	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—CA2—osteoporosis	0.000158	0.00163	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—OXCT1—osteoporosis	0.000158	0.00163	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—MGLL—osteoporosis	0.000154	0.00159	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PNP—osteoporosis	0.000154	0.00158	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—ATIC—osteoporosis	0.000154	0.00158	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—IGF1—osteoporosis	0.000139	0.00143	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—IDH2—osteoporosis	0.000131	0.00135	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—CA2—osteoporosis	0.000131	0.00135	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—OXCT1—osteoporosis	0.000131	0.00135	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—MGLL—osteoporosis	0.000127	0.00131	CbGpPWpGaD
Leucovorin—ABCC3—NRF2 pathway—TGFB1—osteoporosis	0.000124	0.00127	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—CYP27A1—osteoporosis	0.000123	0.00127	CbGpPWpGaD
Leucovorin—ABCC4—Ectoderm Differentiation—MYC—osteoporosis	0.000122	0.00126	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	0.000121	0.00124	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	0.000121	0.00124	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	0.00012	0.00124	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—ACP5—osteoporosis	0.00012	0.00123	CbGpPWpGaD
Leucovorin—ABCC4—NRF2 pathway—TGFB1—osteoporosis	0.000116	0.0012	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	0.000113	0.00116	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—TPI1—osteoporosis	0.000111	0.00115	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—IDH2—osteoporosis	0.000108	0.00112	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—P4HB—osteoporosis	0.000105	0.00108	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—GAPDH—osteoporosis	0.000103	0.00106	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—CYP27A1—osteoporosis	0.000102	0.00105	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—RAP1A—osteoporosis	0.0001	0.00103	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—ACP5—osteoporosis	9.91e-05	0.00102	CbGpPWpGaD
Leucovorin—ABCC2—NRF2 pathway—TGFB1—osteoporosis	9.81e-05	0.00101	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	9.79e-05	0.00101	CbGpPWpGaD
Leucovorin—ABCC3—Transmembrane transport of small molecules—ADCY5—osteoporosis	9.34e-05	0.000962	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—TPI1—osteoporosis	9.22e-05	0.000949	CbGpPWpGaD
Leucovorin—ABCC4—Transmembrane transport of small molecules—ADCY5—osteoporosis	8.78e-05	0.000904	CbGpPWpGaD
Leucovorin—TYMS—Circadian rythm related genes—IL6—osteoporosis	8.72e-05	0.000898	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—P4HB—osteoporosis	8.67e-05	0.000892	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—GAPDH—osteoporosis	8.51e-05	0.000876	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	8.35e-05	0.000859	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—RAP1A—osteoporosis	8.28e-05	0.000853	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—ENO1—osteoporosis	8.09e-05	0.000833	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PSMA2—osteoporosis	7.97e-05	0.000821	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PSMA5—osteoporosis	7.97e-05	0.000821	CbGpPWpGaD
Leucovorin—ABCC2—Transmembrane transport of small molecules—ADCY5—osteoporosis	7.4e-05	0.000762	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—POMC—osteoporosis	7.22e-05	0.000744	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—IGF1—osteoporosis	7.18e-05	0.000739	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—ENO1—osteoporosis	6.7e-05	0.00069	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PSMA2—osteoporosis	6.6e-05	0.000679	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PSMA5—osteoporosis	6.6e-05	0.000679	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—CYP19A1—osteoporosis	6.47e-05	0.000666	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—MYC—osteoporosis	5.85e-05	0.000602	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—CYP19A1—osteoporosis	5.35e-05	0.000551	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—ADCY5—osteoporosis	5.28e-05	0.000544	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—GPX1—osteoporosis	5.27e-05	0.000542	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—MYC—osteoporosis	5.23e-05	0.000539	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—MTHFR—osteoporosis	4.86e-05	0.0005	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—ADCY5—osteoporosis	4.37e-05	0.00045	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—GPX1—osteoporosis	4.36e-05	0.000449	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—TGFB1—osteoporosis	4.3e-05	0.000443	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—MTHFR—osteoporosis	4.02e-05	0.000414	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—POMC—osteoporosis	3.89e-05	0.0004	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—POMC—osteoporosis	3.22e-05	0.000331	CbGpPWpGaD
